Good old days gone for biotech
Offshoring blamed for loss of funding, jobs in industry
By Penni Crabtree
UNION-TRIBUNE STAFF WRITER
November 26, 2006
http://www.signonsandiego.com/news/business/biotech/20061126-9999-1n26biotech.htmlThe business of biotechnology is undergoing a seismic shift, and for some companies there's no surviving the jolt. Take Discovery Partners International. The San Diego company ceased to exist in September, a victim of trends that are reshaping the biotech industry and, at least in the short term, threatening innovation and job creation in the nation's third-largest biotech cluster.
Increasingly, the venture capitalists who fund new life-science companies are shopping for existing drugs to refine instead of backing scientists to make discoveries. When startups are created, they're often minimally staffed. More drug companies are farming out research work to scientists in China, India and Eastern Europe, where tasks are done more cheaply.
For California, the birthplace of biotechnology, the stakes are high. Of the estimated 260,000 Californians who work in the life-science industry, about 70 percent are employed in high-paying jobs in drug, medical-device or diagnostic-tool companies. In San Diego, an estimated 36,600 employees work at about 500 companies, according to BIOCOM, the local biotech trade association.
“Offshoring is what destroyed our business, literally,” said Michael Venuti, former chief executive officer of Discovery Partners. “We had one of the premier chemistry services businesses in 2000, when the company went public, and through 2004 this company was profitable.”